We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Pharmacological, Clinical and Statistical Assessment of a New Tool Available for Pharmacodependence Report Evaluation

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01052675
Recruitment Status : Unknown
Verified January 2010 by Nantes University Hospital.
Recruitment status was:  Recruiting
First Posted : January 20, 2010
Last Update Posted : February 2, 2012
Sponsor:
Information provided by (Responsible Party):

Study Description
Brief Summary:
In France, the Afssaps is the body in charge of the evaluation of pharmacodependance. In order to fulfil its mission, the Afssaps has created a network of 11 Centres for Evaluation and Information on Pharmacodependance (CEIP), coordinated by the Drugs and Psychotropics Unit. Pharmacodependence notifications issued by professionals are collected by each Centre which evaluates them. Nantes' CEIP created an original tool to harmonize case reporting and make it possible to homogeneously evaluate the seriousness of pharmacodependence cases as each CEIP had his own way of analysing his cases. The aim of this study is to assess this tool.

Condition or disease
Drug Abuse Drug Dependence

Study Design

Study Type : Observational
Estimated Enrollment : 5000 participants
Time Perspective: Prospective
Official Title: Pharmacological, Clinical and Statistical Assessment of a New Tool Available for Pharmacodependence Report Evaluation
Study Start Date : January 2008
Groups and Cohorts

Group/Cohort
Pharmacodependance cases
Case report from one of the French CEIP for drug and substance problematic use, abuse or dependence except alcohol and tobacco.


Outcome Measures

Primary Outcome Measures :
  1. Psychometrics properties Evaluation of the new questionnaire centered on addiction to medicine . [ Time Frame: At the beginning of the study ]

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Pharmacodependent patients
Criteria

Inclusion Criteria:

  • case report from one of the French CEIP for drug and substance problematic use, abuse or dependence except alcohol and tobacco.
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01052675


Contacts
Contact: Pascale Jolliet Pascale pascale.jolliet@chu-nantes.fr

Locations
France
Hôpital Pellegrin Recruiting
Bordeaux, France, 33076
CHRU de Caen Recruiting
Caen, France, 14033
CHU de Grenoble Recruiting
Grenoble, France, 38043
Centre Antipoison - Centre de Pharmacovigilance Recruiting
Lyon, France, 69424
Hôpital Salvator Recruiting
Marseille, France, 13274
Hôpital Lapeyronie Recruiting
Montpellier, France, 34295
CHU de Nancy Recruiting
Nancy, France, 54035
CHU de Nantes Recruiting
Nantes, France, 44093
Hôpital Fernand Widal Recruiting
Paris, France, 75475
Faculté de médecine Recruiting
Toulouse, France, 31073
Sponsors and Collaborators
Nantes University Hospital
Investigators
Study Director: Jolliet Pascale, MD Nantes's University Hospital
More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Nantes University Hospital
ClinicalTrials.gov Identifier: NCT01052675     History of Changes
Other Study ID Numbers: BRD07/10-C
First Posted: January 20, 2010    Key Record Dates
Last Update Posted: February 2, 2012
Last Verified: January 2010

Keywords provided by Nantes University Hospital:
Drug and substance problematic use, abuse or dependence

Additional relevant MeSH terms:
Substance-Related Disorders
Chemically-Induced Disorders
Mental Disorders